Europe Single-use Bioreactors Market by Size, Share, Growth and Forecast

1. Europe Single-use Bioreactors Market to be Worth $3.34 Billion by 2030 Meticulous Research®—a leading global market research company, published a research report titled‘Europe Single-use Bioreactors Marketby Product [Systems, Media Bags (2D, 3D), Filtration Assemblies], Type [Stirred Tank, Wave Induced], Cell [Mammalian, Bacterial, Yeast], Application [Commercial (Mab, Vaccine), Research], End User – Forecast to 2030.’ According to this latest publication from Meticulous Research®, the Europe single-use bioreactors market is projected to reach $3.34 billion by 2030, at a CAGR of 15.3%. Increasing adoption of disposable technologies in the pharmaceutical and biotechnology industries, capacity expansions of biopharmaceutical plants, increasing pharmaceutical R&D expenditures, the rising adoption of biosimilars, and the growing prevalence of chronic diseases owing to the aged population are the factors driving the growth of this market. Europe Single-use Bioreactors Market: Future Outlook The Europe single-use bioreactors market is segmented by Product {Single use Bioreactor Systems (Upto 10L, 11L-500L, 501L-1000L, and above 1001L), Media Bags (2D, 3D, and Linear), Filtration Assemblies, and Other Products}, Type (Stirred-Tank, Wave-Induced, and Other Types), Cell Type (Mammalian Cells, Bacterial Cells, Yeast Cells, and Other Cell Types), Application [Commercial Bioproduction (mAb Production, Vaccine Production, Therapeutic Protein Production, and Cell and Gene Therapy) Research Bioproduction], End User {Pharmaceutical and Biopharmaceutical Companies; Contract Research Organizations and Contract Development and Manufacturing Organizations (CDMO); and Academic and Research Institutes}, and Geography. The study also evaluates industry competitors and analyzes their country-level market share. Download Free Research PDF @ https://www.meticulousresearch.com/download-sample- report/cp_id=5552 Based on product,the Europe single-use bioreactor market is segmented into single-use bioreactor systems, media bags, filtration assemblies, and other products. In 2023, the single-use bioreactor systems segment is expected to account for the largest share of the market. The major reasons behind this share are their advantages. These advantages include lesser cleaning requirements, more flexibility, a smaller footprint, less capital investment, and reduced risk of cross-contamination. Moreover, vendors’ focus on large-scale bio-manufacturing supported the growth. Also, increasing demand by biopharma companies to reduce excess costs when using traditional instruments raises their adoption. Among the type, in 2023, the stirred-tank bioreactors segment is expected to account for the largest share of the market. Increased use of stirred-tank bioreactors for CHO cell lines & suspension culture and large volume bio-production along with the latest design compared to traditional ones supported the share. Among the cell type, in 2023, the mammalian cells segment is expected to account for the largest share of the market. Mammalian cells are considered a widely adopted experimental model, and hence their use for commercial & research bioproduction, like developing complex biomolecules such as monoclonal antibodies and therapeutic proteins and extensive use in clinical research for the majority of experiments supported the market share. Among the application, in 2023, the commercial bio-production segment is expected to account for the largest share of the market. The large market share of this segment is attributed to the rising

2. production of biosimilars, an increasing number of genetic & rare diseases, and government support for the production of vaccines & immunization. Among the end user, the contract development and manufacturing organizations (CDMOs) and contract research organizations (CROs) segment is projected to register the highest CAGR during the forecast period. The growth of this segment is driven by the outsourcing by the pharmaceutical and biopharmaceutical companies to CDMOs, key players’ preference for inorganic growth strategies, and expansion strategy by CDMOs. For instance, in July 2021, Viralgen VC (Spain) opened its new manufacturing facility in Basque, Italy. This facility is associated with adeno-associated virus gene therapy production. Geographic Review This research report analyzes major geographies and comprehensively analyzes European countries Germany, France, the U.K., Italy, Spain, Switzerland, Ireland, Denmark, Belgium, and the Rest of Europe. In 2023, Germany is expected to account for the largest share of the Europe single-use bioreactors market. The large share of this market is attributed to the increasing sales of drugs, support from government and regulatory authorities to promote the use of biopharmaceuticals for various health indications, and various companies expanding their manufacturing capacities as well as their operations. Quick Buy – Europe Single-use Bioreactors Market - Opportunity Analysis and Industry Forecast (2023-2030), Research Report: https://www.meticulousresearch.com/Checkout/77071228 Key Players The key players profiled in theEurope single-use bioreactors market reportare Merck KGaA (Germany), Danaher Corporation (U.S.), Sartorius AG (Germany), Thermo Fisher Scientific Inc. (U.S.), Eppendorf AG (Germany), Solaris Biotechnology srl (Italy), Cellexus International Ltd. (U.K.) CESCO Bioengineering Co., Ltd. (Taiwan), PBS Biotech, Inc. (U.S.), Solida Biotech GmbH (Germany), and Infors AG (Switzerland). Scope of the Report: Europe Single-use Bioreactors Market, by Product • Single-use Bioreactor Systems oUpto 10L o11L-500L o501-1000L oAbove 1001L • Media Bags o2D o3D oLinear • Filtration Assemblies

3. • Other Products (Note: Other products include pumps, single-use vessels, tubing & connectors, gas components, rockers, cables, sensors/probes, and films.) Europe Single-use Bioreactors Market, by Type • Stirred-tank Bioreactors • Wave-induced Bioreactors • Other Types (Note: Other types include hybrid bioreactors, bubble-column, and bioreactors with vertically perforated discs.) Europe Single-use Bioreactors Market, by Cell Type • Mammalian cells • Bacterial Cells • Yeast Cells • Other Cell Types (Note: Other cell types include plant cells and insect cells.) Europe Single-use Bioreactors Market, by Application • Commercial Bioproduction oMonoclonal Antibody Production oVaccine Production oTherapeutic Protein Production oCell & Gene Therapy • Research Bioproduction Europe Single-use Bioreactors Market, by End User • Pharmaceutical and Biopharmaceutical Companies • Contract Development and Manufacturing Organizations (CDMO) and Contract Research Organizations (CROs) • Academic and Research Institutes Europe Single-use Bioreactors Market, by Country • Germany • U.K. • France • Italy • Switzerland

4. • Ireland • Denmark • Belgium • Spain • Rest of Europe Request Free Research Report Sample @ https://www.meticulousresearch.com/request-sample- report/cp_id=5552